DEFINITIVE PROXY STATEMENT

Company

Sonoma Pharmaceuticals, Inc.

Filed

July 29, 2013

Period of Report

September 12, 2013

Accession Number

0001019687-13-002737

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →